Literature DB >> 21391409

Disparities in ADHD assessment, diagnosis, and treatment.

Christopher P Morley1.   

Abstract

The regional study by Baumgardner and colleagues converges with existing literature to clearly show that the distribution of ADHD diagnosis falls along socioeconomic lines, according to the relative wealth of neighborhoods. This adds additional evidence that trends in the diagnosis and treatment for ADHD in children move in the exact opposite direction from those who are at highest risk for meeting criteria, for experiencing impairment, for and downstream socioeconomic sequelae. Contributing factors, such as marginal diagnoses (such as when parent and teacher symptom reports diverge), inadequate insurance coverage, limited time, and lack of familiarity and comfort with diagnostic and prescribing guidelines, may leave the door open to misdiagnosis and treatment. In some cases, this may take the form of over-diagnosis and over-treatment, in the form of false-positive diagnoses with ADHD, and treatments for it, or may alternatively take the form of false-negative diagnoses. If the social and epidemiological data are any indication, it is furthermore likely that such false-positive or false-negative outcomes may break along socioeconomic lines. Increased use of formal screening tools, increased curricular time for mental health in primary care residencies, support for physicians in the field in the form of referral options and remote consultation and support, may all serve to improve quality of care for individual patients, and may also serve to regularize treatment across socioeconomic and sociodemographic lines, hence reducing disparities. Further research is needed to study the root causes and dynamics that create such disparities, but the steps outlined above may help in the near term.

Entities:  

Mesh:

Year:  2010        PMID: 21391409     DOI: 10.2190/PM.40.4.b

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  7 in total

1.  Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth.

Authors:  Cynthia P Paidipati; Bridgette Brawner; Ricardo Eiraldi; Janet A Deatrick
Journal:  J Am Psychiatr Nurses Assoc       Date:  2017-01-11       Impact factor: 2.385

2.  Caregivers' distress: youth with attention-deficit/hyperactivity disorder and comorbid disorders assessed via telemental health.

Authors:  Carol Rockhill; Heather Violette; Ann Vander Stoep; Sarah Grover; Kathleen Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-08       Impact factor: 2.576

3.  Racial and Ethnic Disparities in ADHD Diagnosis and Treatment.

Authors:  Tumaini R Coker; Marc N Elliott; Sara L Toomey; David C Schwebel; Paula Cuccaro; Susan Tortolero Emery; Susan L Davies; Susanna N Visser; Mark A Schuster
Journal:  Pediatrics       Date:  2016-08-23       Impact factor: 7.124

4.  Were low transferrin levels associated with ADHD symptoms?

Authors:  Rongwang Yang; Suhan Zhang; Rong Li; Zhengyan Zhao
Journal:  Psychiatry Investig       Date:  2012-11-14       Impact factor: 2.505

5.  The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins.

Authors:  Yaarit Simchon Tenenbaum; Abraham Weizman; Moshe Rehavi
Journal:  J Mol Neurosci       Date:  2015-07-08       Impact factor: 3.444

6.  ADHD remission, inclusive special education, and socioeconomic disparities.

Authors:  Margeum Kim; Marissa D King; Jennifer Jennings
Journal:  SSM Popul Health       Date:  2019-05-30

7.  Guideline adherence in the management of attention deficit hyperactivity disorder in children: An audit of selected medical records in three Australian states.

Authors:  Louise A Ellis; Brette Blakely; Philip Hazell; Sue Woolfenden; Harriet Hiscock; Vanessa Sarkozy; Bronwyn Gould; Peter D Hibbert; Gaston Arnolda; Hsuen P Ting; Louise K Wiles; Charlotte J Molloy; Kate Churruca; Meagan Warwick; Jeffrey Braithwaite
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.